+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?



Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?



Gynecologic and Obstetric Investigation 81(1): 28-33



This study measured the serum levels of complement component (C)3a and C5a and the placental expressions of C3a receptor (R) and C5aR to determine a potential correlation with circulating angiotensin II type 1 (AT1) receptor agonistic autoantibody (AT1-AA) in severe pre-eclampsia. A total of 118 women were recruited and divided into 2 groups: the control group (normotensive preterm pregnancies, n = 66) and severe pre-eclampsia group (n = 52). Levels of C3a, C5a and AT1-AA in serum were measured by enzyme-linked immunosorbent assay and C3aR and C5aR in placenta by Western blotting. Levels of C3a, C5a and AT1-AA in serum from the severe pre-eclampsia group were significantly higher than in controls (p < 0.05). Placental expression of C3aR and C5aR in the pre-eclampsia group was lower than that in controls (p < 0.05). There were significant positive correlations between levels of C3a, C5a and AT1-AA in serum from the pre-eclampsia group (p < 0.05). In contrast, there was no correlation between C3aR and C5aR in the placenta and AT1-AA in serum in the pre-eclampsia group (p > 0.05). Increased C3a, C5a and AT1-AA in the serum provide indirect evidence that AT1-AA-mediated activation contributes to activate complement, which is a key mechanism underlying the pathogenesis of severe pre-eclampsia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057475268

Download citation: RISBibTeXText

PMID: 26485247

DOI: 10.1159/000440651


Related references

Levels of complement receptor type one (CR1, CD35) on erythrocytes, circulating immune complexes and complement C3 split products C3d and C3c are not changed by short-term physical exercise or training. International Journal of Sports Medicine 13(2): 172-175, 1992

Complement c 3b receptors on erythrocytes circulating immune complexes and complement c 3 split products in patients with primary sjogren's syndrome. Arthritis and Rheumatism 29(7): 857-862, 1986

Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia. Journal of Hypertension 33(5): 1046-1056, 2015

Progress toward identifying potential markers for preeclampsia: role of agonistic autoantibody to the angiotensin II type I receptor. Hypertension 55(2): 236-237, 2010

Response to questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia: There is no single universal preeclampsia cause. Hypertension (Baltimore) 50(1): E4, 2007

Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51(4): 1010-1019, 2008

Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. Journal of Clinical Endocrinology and Metabolism 91(6): 2424-2427, 2006

Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension 60(3): 712-721, 2012

Use of complement split products to distinguish active systemic lupus erythematosus sle from preeclampsia. American Journal of Obstetrics & Gynecology 164(1 Part 2): 243, 1991

Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products. Journal of Maternal-Fetal and Neonatal Medicine 23(7): 646-657, 2010

Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50(2): 269-275, 2007

Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension 50(1): E3; Author Reply E4-E3; Author Reply E4, 2007

Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia. Disease Markers 2015: 263109, 2015